SEC Form 4 · accession 0001572426-16-000218
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George W Gunn
Director
Period of report
Sep 5, 2016
Accepted (ET)
Sep 7, 2016 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 5, 2016 | A | 20,000 | $0.00 | A | 37,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1 | $0.125 | Sep 5, 2016 | M | 3,600 | A | Jul 1, 2017 | Jul 1, 2021 | Ordinary Shares | 3,600 | 3,600 | D |
Explanation of responses
- F13,600 of the Restricted Share Units shall vest and become convertible on 7/1/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting.